World-first: Experimental CRISPR technology removes detectable cancer cells in 13-year-old
Alyssa received genetically modified cells that could chase and kill the cancerous T-cells without attacking each other.
| Dec 12, 2022 04:55 AM EST
Created: Dec 12, 2022 04:55 AM EST
Alyssa, from Leicester, became the first reported patient in the world to receive base-edited T-cells at Great Ormond Street Hospital for Children.